Back to Atlas
CTransientStandard research/education caution
CMP-0322
Not approved; prohibited in sport
Epi-dihydrotestosterone
Endocrine / Androgen
Androgenic steroid research/doping relevance
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Androgen isomer
- Primary mechanism
- AR agonist/isomeric DHT; A:A ratio not established
- Primary market use
- Androgen research
Pharmacology
- Molecular weight (Da)
- 290.44
- Oral bioavailability
- Not established
- Half-life
- ~1–12 h provisional PK estimate
- Route tags
- Route-dependent / verify
- Evidence level
- Doping list/research
- Clinical status
- Not approved; prohibited in sport
- Value-for-money score
- 1 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Sparse practical data; included due WADA listing.